Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma

por de Lange, Mark J., Nell, Rogier J., van der Velden, Pieter A.
Publicado 2021

Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth

por el Filali, Mariam, Homminga, Irene, Maat, Willem, van der Velden, Pieter A., Jager, Martine J.
Publicado 2008

Quantification of DNA methylation independent of sodium bisulfite conversion using methylation‐sensitive restriction enzymes and digital PCR

por Nell, Rogier J., van Steenderen, Debby, Menger, Nino V., Weitering, Thomas J., Versluis, Mieke, van der Velden, Pieter A.
Publicado 2020

Bevacizumab and intraocular tumors: an intriguing paradox

por el Filali, Mariam, Ly, Long V., Luyten, Gregorius P.M., Versluis, Mieke, Grossniklaus, Hans E., van der Velden, Pieter A., Jager, Martine J.
Publicado 2012

Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy

por Sluijter, Marjolein, van der Sluis, Tetje C., van der Velden, Pieter A., Versluis, Mieke, West, Brian L., van der Burg, Sjoerd H., van Hall, Thorbald
Publicado 2014

EMT-associated factors promote invasive properties of uveal melanoma cells

por Asnaghi, Laura, Gezgin, Gülçin, Tripathy, Arushi, Handa, James T., Merbs, Shannath L., van der Velden, Pieter A., Jager, Martine J., Harbour, J. William, Eberhart, Charles G.
Publicado 2015

Mrassf1a-Pap, a Novel Methylation-Based Assay for the Detection of Cell-Free Fetal DNA in Maternal Plasma

por van den Oever, Jessica M. E., Balkassmi, Sahila, Segboer, Tim, Verweij, E. Joanne, van der Velden, Pieter A., Oepkes, Dick, Bakker, Egbert, Boon, Elles M. J.
Publicado 2013

Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma

por Nell, Rogier J., Menger, Nino V., Versluis, Mieke, Luyten, Gregorius P. M., Verdijk, Robert M., Madigan, Michele C., Jager, Martine J., van der Velden, Pieter A.
Publicado 2021

In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target

por ten Voorde, Anna M.W., Wierenga, Annemijn P.A., Nell, Rogier J., van der Velden, Pieter A., Luyten, Gregorius P.M., Verdijk, Robert M., Jager, Martine J.
Publicado 2021

LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma

por Souri, Zahra, Wierenga, Annemijn P. A., Kroes, Wilma G. M., van der Velden, Pieter A., Verdijk, Robert M., Eikmans, Michael, Luyten, Gregorius P. M., Jager, Martine J.
Publicado 2021

Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma

por Gelmi, Maria Chiara, Verdijk, Robert M., Houtzagers, Laurien E., van der Velden, Pieter A., Kroes, Wilma G. M., Luyten, Gregorius P. M., Vu, T. H. Khanh, Jager, Martine J.
Publicado 2023

Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma

por Souri, Zahra, Jochemsen, Aart G., Wierenga, Annemijn P. A., Kroes, Wilma G. M., Verdijk, Rob M., van der Velden, Pieter A., Luyten, Gregorius P. M., Jager, Martine J.
Publicado 2021

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy

por Cao, Jinfeng, Heijkants, Renier C., Jochemsen, Aart G., Dogrusöz, Mehmet, de Lange, Mark J., van der Velden, Pieter A., van der Burg, Sjoerd H., Jager, Martine J., Verdijk, Robert M.
Publicado 2016

Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?

por van Weeghel, Christiaan, Wierenga, Annemijn P. A., Versluis, Mieke, van Hall, Thorbald, van der Velden, Pieter A., Kroes, Wilma G. M., Pfeffer, Ulrich, Luyten, Gregorius P. M., Jager, Martine J.
Publicado 2019

MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3

por Souri, Zahra, Wierenga, Annemijn P. A., Kiliç, Emine, Brosens, Erwin, Böhringer, Stefan, Kroes, Wilma G. M., Verdijk, Robert M., van der Velden, Pieter A., Luyten, Gregorius P. M., Jager, Martine J.
Publicado 2021

Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma

por Versluis, Mieke, de Lange, Mark J., van Pelt, Sake I., Ruivenkamp, Claudia A. L., Kroes, Wilma G. M., Cao, Jinfeng, Jager, Martine J., Luyten, Gre P. M., van der Velden, Pieter A.
Publicado 2015

Ischemia Is Related to Tumour Genetics in Uveal Melanoma

por Brouwer, Niels J., Wierenga, Annemijn P. A., Gezgin, Gülçin, Marinkovic, Marina, Luyten, Gregorius P. M., Kroes, Wilma G. M., Versluis, Mieke, van der Velden, Pieter A., Verdijk, Robert M., Jager, Martine J.
Publicado 2019

HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma

por Souri, Zahra, Jochemsen, Aart G., Versluis, Mieke, Wierenga, Annemijn P.A., Nemati, Fariba, van der Velden, Pieter A., Kroes, Wilma G.M., Verdijk, Robert M., Luyten, Gregorius P.M., Jager, Martine J.
Publicado 2020

Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma

por Souri, Zahra, Wierenga, Annemijn P. A., van Weeghel, Christiaan, van der Velden, Pieter A., Kroes, Wilma G. M., Luyten, Gregorius P. M., van der Burg, Sjoerd H., Jochemsen, Aart G., Jager, Martine J.
Publicado 2019

Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients

por van Dijk, Elon H. C., Duits, Danique E. M., Versluis, Mieke, Luyten, Gregrorius P. M., Bergen, Arthur A. B., Kapiteijn, Ellen W., de Lange, Mark J., Boon, Camiel J. F., van der Velden, Pieter A.
Publicado 2016